Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimes

van de Groep, Liza D; van Thor, Mitch C J; Mager, Johannes J; Post, Marco C

doi:https://doi.org/10.1007/s00380-021-01852-9

Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimes

DSpace/Manakin Repository

Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimes

van de Groep, Liza D; van Thor, Mitch C J; Mager, Johannes J; Post, Marco C

(2021) Heart and Vessels, volume 36, issue 10, pp. 1607 - 1608

(Comment)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Anticoagulants, Balloon pulmonary angioplasty (BPA), Chronic thromboembolic pulmonary hypertension (CTEPH), Direct oral anticoagulants, Vitamin K antagonist, Cardiology and Cardiovascular Medicine, Letter

DOI: https://doi.org/10.1007/s00380-021-01852-9

ISSN: 0910-8327

Publisher: Springer Japan

(Peer reviewed)